search
OHSU
Trends
- 1OHSU-Listed Startup Lucioole Targets Mitochondrial DNA Therapeutics▼Luciole Pharmaceuticals: OHSU-listed mitochondrial DNA therapeutics startup
Luciole Pharmaceuticals is drawing attention as a biotech startup focused on mitochondrial DNA therapeutics, listed as affiliated with Oregon Health & Science University. The company works on treatments aimed at mitochondria, the energy-producing structures in cells whose genetic defects cause a range of rare and serious diseases. Details on funding, clinical programs and leadership remain limited, with observers watching whether the OHSU connection signals a pipeline of university research moving toward drug development.
- 2OHSU-backed CNS biotech Autobahn Therapeutics▼Autobahn Therapeutics: OHSU-backed CNS regenerative medicine spinout
Autobahn Therapeutics is a regenerative medicine spinout focused on the central nervous system, backed by Oregon Health & Science University. The company is developing therapies aimed at repairing damaged neural tissue, building on research originating at OHSU. It is listed among university-affiliated biotech ventures in deal databases tracking spinouts.
- 3OHSU wins $4.6 million to expand rural clinical trials▼OHSU secures $4.6 million to expand clinical trials in underserved rural communities
Oregon Health & Science University has received $4.6 million in funding to expand clinical trials in underserved rural communities. The investment aims to broaden access to medical research for patients outside urban centers, who are often underrepresented in clinical studies. The announcement was carried by OHSU's own news service.